Mark J. Enyedy - Feb 4, 2022 Form 4 Insider Report for ImmunoGen, Inc. (IMGN)

Role
Chief Executive Officer, Director
Signature
/s/ Renee Lentini, attorney in fact
Stock symbol
IMGN
Transactions as of
Feb 4, 2022
Transactions value $
$5,852,000
Form type
4
Date filed
2/8/2022, 04:34 PM
Previous filing
Jul 2, 2021
Next filing
Dec 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGN Stock Option (right to buy) Award $5.85M +1.1M $5.32 1.1M Feb 4, 2022 Common Stock 1.1M $5.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest over a four-year period, with 25% of the shares vesting on the one year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant.